AZD1775 Combined With Olaparib in Patients With Refractory Solid Tumors

Clinical trial NCT02511795 · COMPLETED

Trial details

NCT number: NCT02511795
Sponsor: AstraZeneca
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Refractory Solid Tumours Relapsed Small Cell Lung Cancer (SCLC)

Start date: 2015-08-06
Primary completion: 2019-04-25
Enrollment: 128

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.